Literature DB >> 18931983

[Eccrine adenocarcinoma in a patient with familial breast carcinoma].

M Wosnitza1, A Rübben, N Pallua, M Megahed.   

Abstract

A 67-year-old patient developed a subcutaneous, non-tender nodule in her left groin over a period of about seven years. The patient underwent surgery and 4 procedures were required to obtain complete excision. The histopathologic findings showed eccrine adenocarcinoma, a member of the heterogeneous group of sweat gland tumors which occur primarily in adults with a peak of 50-60 years of age. Sweat gland carcinomas are extremely rare neoplasms of the skin and exhibit a slow growth rate with a rather high local recurrence rate. The tumor has a disposition to metastasize and shows a poor response rate to adjuvant therapy regimens. Therefore wide, deep surgical excision with an excision margin of 2-3 cm is the treatment of choice. Nevertheless there are some case reports on successful therapy of a metastasized sweat gland carcinoma with 5-fluorouracil and tamoxifen. Here further studies are needed to achieve a better survival rate for patients with metastatic disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931983     DOI: 10.1007/s00105-008-1652-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  12 in total

1.  Sweat gland carcinoma with multiple local recurrences: a case report.

Authors:  D Panoussopoulos; A Darom; A C Lazaris; P Misthos; K Papadimitriou; G Androulakis
Journal:  Adv Clin Path       Date:  1999-07

2.  Sweat gland carcinoma: a clinico-pathological reappraisal.

Authors:  D L Mitts; M T Smith; L Russell; G A Bannayan; A B Cruz
Journal:  J Surg Oncol       Date:  1976       Impact factor: 3.454

Review 3.  [Sweat gland carcinomas of the skin].

Authors:  A Rütten; L Requena
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

4.  Metastatic sweat gland carcinoma: response to 5-fluorouracil infusion.

Authors:  J D Swanson; R Pazdur; E Sykes
Journal:  J Surg Oncol       Date:  1989-09       Impact factor: 3.454

Review 5.  Microcystic adnexal carcinoma: report of 13 cases and review of the literature.

Authors:  S Snow; D D Madjar; S Hardy; M Bentz; M J Lucarelli; R Bechard; W Aughenbaugh; T McFadden; H Sharata; C Dudley; A Landeck
Journal:  Dermatol Surg       Date:  2001-04       Impact factor: 3.398

6.  Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma.

Authors:  Paul N Bogner; Douglas R Fullen; Lori Lowe; Augusto Paulino; J Sybil Biermann; Vernon K Sondak; Lyndon D Su
Journal:  Cancer       Date:  2003-05-01       Impact factor: 6.860

Review 7.  Eccrine sweat gland carcinoma: a case report and review of diagnosis and treatment.

Authors:  I A Voutsadakis; H W Bruckner
Journal:  Conn Med       Date:  2000-05

8.  Successful adjuvant tamoxifen therapy for estrogen receptor-positive metastasizing sweat gland adenocarcinoma: need for a clinical trial?

Authors:  Ursula Schröder; Volker Dries; Jens Peter Klussmann; Claus Wittekindt; Hans Edmund Eckel
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-03       Impact factor: 1.547

9.  Her-2 expression in cutaneous eccrine and apocrine neoplasms.

Authors:  Kim M Hiatt; Jessica L Pillow; Bruce R Smoller
Journal:  Mod Pathol       Date:  2004-01       Impact factor: 7.842

10.  Metastatic sweat gland adenocarcinoma: A clinico-pathological dilemma.

Authors:  RD Sharma; Rohini Badran; Vinay Singhal; Sunita Saxena; Anju Bansal
Journal:  World J Surg Oncol       Date:  2003-08-01       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.